Elevated acute-phase biomarkers, such as the C-reactive protein (CRP) and YKL-40 (also called chitinase-3-like-1 protein, CHI3L1) [14], are associated with a poor prognosis for various types of cancer, including CRC [15,16,17,18]. The gene discussed is CRP; the disease is cancer.